These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6751333)

  • 1. Hypoxic cell radiosensitizers as potential adjuvants to conventional chemotherapy for the treatment of cancer.
    Millar BC
    Biochem Pharmacol; 1982 Aug; 31(15):2439-45. PubMed ID: 6751333
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
    Coleman CN
    Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-nitro radiation sensitizers.
    Shenoy MA; Singh BB
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Sep; 48(3):315-26. PubMed ID: 3875573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of nitroaromatic compounds as hypoxic cell radiosensitizers.
    Wardman P
    Curr Top Radiat Res Q; 1977 Aug; 11(4):347-98. PubMed ID: 330116
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitroreductase-induced binding of nitroaromatic radiosensitizers to unsaturated lipids. Nitroxyl adducts.
    Raleigh JA; Shum FY; Liu SF
    Biochem Pharmacol; 1981 Nov; 30(21):2921-5. PubMed ID: 6274354
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurotoxic radiosensitizers and head and neck cancer patients--how many will benefit?
    Cummings BJ; Thomas GM; Rauth AM; Sorrenti V; Black B; Bush RS
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):343-5. PubMed ID: 7107351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of the radiation effects for overcoming radiation-resistant hypoxic tumor tissue].
    Moldenhauer H; Rose H; Saul G; Wolf G; Kehrberg G
    Radiobiol Radiother (Berl); 1983; 24(5):597-614. PubMed ID: 6316407
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical modifiers of cancer treatment.
    Coleman CN; Bump EA; Kramer RA
    J Clin Oncol; 1988 Apr; 6(4):709-33. PubMed ID: 3282035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Randomizations!].
    Piedbois P; Buyse M
    Cancer Radiother; 1998 Dec; 2(6):663-4. PubMed ID: 9922769
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxicity of nitro compounds toward hypoxic mammalian cells in vitro: dependence on reduction potential.
    Adams GE; Stratford IJ; Wallace RG; Wardman P; Watts ME
    J Natl Cancer Inst; 1980 Mar; 64(3):555-60. PubMed ID: 6928241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemotherapy and radiotherapy in patients with brain tumors.
    Glantz MJ; Kim L; Choy H; Akerley W
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):78-82. PubMed ID: 10550830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical radiation sensitizers and protectors: recent developments.
    Kim JH; Chu FC
    Clin Bull; 1981; 11(1):5-11. PubMed ID: 6268335
    [No Abstract]   [Full Text] [Related]  

  • 13. Sulfoglycolipids as candidate antiangiogenic radiosensitizers.
    Miura M; Sakimoto I; Ohta K; Sugawara F; Sakaguchi K
    Anticancer Drugs; 2007 Jan; 18(1):1-5. PubMed ID: 17159496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation sensitization with redox modulators: a promising approach.
    Rosenberg A; Knox S
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):343-54. PubMed ID: 16414370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status of anticancer chemotherapy. Progress in concept, methods and means].
    Chauvergne J
    Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):271-89. PubMed ID: 897407
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemical modification of radiation and chemotherapy.
    Brown JM; Hall EJ; Hirst DG; Kinsella TJ; Kligerman MM; Mitchell JB; Travis EJ; Valeriote F
    Am J Clin Oncol; 1988 Jun; 11(3):288-303. PubMed ID: 3289362
    [No Abstract]   [Full Text] [Related]  

  • 17. The hypoxic tumor cell: a target for selective cancer chemotherapy.
    Kennedy KA; Teicher BA; Rockwell S; Sartorelli AC
    Biochem Pharmacol; 1980 Jan; 29(1):1-8. PubMed ID: 6987986
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitro reduction as an electronic switch for bioreductive drug activation.
    Siim BG; Denny WA; Wilson WR
    Oncol Res; 1997; 9(6-7):357-69. PubMed ID: 9406242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
    Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
    Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioreductive mechanisms.
    Workman P
    Int J Radiat Oncol Biol Phys; 1992; 22(4):631-7. PubMed ID: 1544830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.